Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
Dr. Xiao brings more than 25 years of drug discovery experience and will oversee Nona’s AI-driven platform and global scientific strategy.
- On Wednesday, Nona Biosciences appointed Dr. Josh Xiao as Chief Scientific Officer. Xiao will lead the company's global scientific strategy and oversee the evolution of its technology platforms.
- Dr. Xiao brings more than 25 years of experience in drug discovery to the role. Dr. Di Hong, Chief Executive Officer of Nona Biosciences, noted his extensive background in translational medicines will be instrumental to the company's growth.
- "I am thrilled to join the Nona Biosciences team, and very excited to help strengthen and expand our technology platforms," said Dr. Josh Xiao. He will oversee H2L2 Harbour Mice and the Hu-mAtrIxTM AI-driven drug discovery platform.
- Reporting directly to Dr. Di Hong, Dr. Xiao will lead global Project Leaders to enhance project execution. Based in China, he will establish a structured framework to deepen scientific insight into partner needs.
- Prior to this, Dr. Xiao led scientific teams at Amgen and Takeda. He holds a Ph.D. in Biochemistry from Louisiana State University and completed postdoctoral training at Columbia University.
48 Articles
48 Articles
The Conway Daily Sun
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
CAMBRIDGE, Mass., May 6, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will…
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation - PressReach
CAMBRIDGE, Mass., May 6, 2026 /PRNewswire/ — Nona Biosciences (“Nona” or the “Company”), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will be based in both US and China and report directly to Dr. Di Hong, Chief Executive Officer of Nona Biosciences. In this role, Dr. Xiao will lead the develo…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
